Potential Benefit of Low-Dose Candesartan in Trastuzumab-Induced Cardiotoxic Effects
JAMA Oncol
.
2017 Feb 1;3(2):279.
doi: 10.1001/jamaoncol.2016.3637.
Authors
Seongseok Yun
1
,
Rostam Khoubyari
2
,
Ivo Abraham
3
Affiliations
1
Department of Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
2
Department of Cardiology, University of Arizona, Tucson.
3
Arizona Cancer Center, University of Arizona, Tucson4Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson.
PMID:
27787557
DOI:
10.1001/jamaoncol.2016.3637
No abstract available